IRON
NASDAQ
US
Disc Medicine, Inc. - Common Stock
$65,18
▲ +$0,40
(+0,62%)
Vol 570K
4
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$3.0B
ROE
-31,6%
D/E
5,05
Beta
0,88
52W
$31–$100
Konsensus Wall Street
19 analis · Apr 20267
Beli Kuat
11
Beli
1
Tahan
0
Jual
0
Jual Kuat
94,7%
Peringkat Beli
Grafik Harga
Saham Serupa
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110,3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B
SRPT
Sarepta Therapeutics Inc
$2.3B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $-1,78 | $-1,64 | +$0,14 |
| Sep 2025 | $-1,49 | $-1,77 | $-0,28 |
| Jun 2025 | $-1,18 | $-1,58 | $-0,40 |
| Mar 2025 | $-1,16 | $-1,02 | +$0,14 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | — | — | — | — | — |
| Laba Bersih | — | -$29.5M | -$34.1M | -$55.2M | -$62.3M | -$60.5M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -26.6% | -26.6% | -26.6% | -26.6% | -31.6% | -31.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 4.68 | 4.68 | 4.68 | 4.68 | 5.05 | 5.05 |
| Current Ratio | 32.11 | 32.11 | 32.11 | 32.11 | 23.45 | 23.45 |
Rasio Utama
ROA (TTM)
-29,0%
P/B
4,2
EPS (TTM)
$-5,35
CF/Share
$-3,60
52W High
$99,50
52W Low
$30,82
$30,82
Rentang 52 Minggu
$99,50
Kesehatan Keuangan
Arus Kas Bebas
-$43.3M
Utang Bersih
-$60.1M
Kas
$91.1M
Total Utang
$31.0M
Per tanggal Des 31, 2025
Як IRON виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка IRON vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
—
▼
0%
di bawah
rekan
(12,9)
vs Rekan
vs Industri
Overvalued
P/B
4,3
▲
73%
di atas
rekan
(2,5)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість IRON vs аналоги Biotechnology
ROE
-31,6%
▲
53%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Tingkat atas
Net margin
—
▼
0%
di bawah
rekan
(-286,8%)
vs Rekan
vs Industri
Tingkat atas
Валова маржа
—
▼
0%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Sejajar
ROA
-29,0%
▲
38%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя IRON vs аналоги Biotechnology
D/E ratio
5,1
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
23,5
▲
428%
di atas
rekan
(4,4)
vs Rekan
vs Industri
Likuiditas kuat
Beta
0,9
▼
10%
di bawah
rekan
(1,0)
vs Rekan
vs Industri
Kurang volatil
Радар фундаменталів IRON
IRON
Median rekan
Industri
IRON прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
IRON vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
SAVAGE WILLIAM JACOB
Officer · Mar 02
7378 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 25
353 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 18
11156 shs
QUISEL JOHN D
Chief Executive Officer · Feb 17
13264 shs
STEPHENSON PAMELA
Officer · Feb 17
5531 shs
YU JONATHAN YEN-WEN
Chief Operating Officer · Feb 17
3231 shs
SAVAGE WILLIAM JACOB
Officer · Feb 17
3256 shs
KHARA RAHUL
Officer · Feb 17
2853 shs
QUISEL JOHN D
Chief Executive Officer · Feb 10
55200 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 10
19000 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 34,5%FMR, LLC
14,28%
$329.6M
Blackrock Inc.
5,96%
$137.6M
RA Capital Management, L.P.
5,18%
$119.5M
Vanguard Group Inc
4,63%
$106.9M
Price (T.Rowe) Associates I…
4,45%
$102.7M
Per tanggal Des 31, 2025